Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
<p>Abstract</p> <p>A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc.</p>
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/10/1/111 |
| _version_ | 1811285741962002432 |
|---|---|
| author | Shakur Haleema Roberts Ian |
| author_facet | Shakur Haleema Roberts Ian |
| author_sort | Shakur Haleema |
| collection | DOAJ |
| description | <p>Abstract</p> <p>A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc.</p> |
| first_indexed | 2024-04-13T02:49:24Z |
| format | Article |
| id | doaj.art-4c9e8d033c86456f99d5a4f944509c79 |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-04-13T02:49:24Z |
| publishDate | 2009-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-4c9e8d033c86456f99d5a4f944509c792022-12-22T03:05:54ZengBMCTrials1745-62152009-12-0110111110.1186/1745-6215-10-111Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' replyShakur HaleemaRoberts Ian<p>Abstract</p> <p>A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc.</p>http://www.trialsjournal.com/content/10/1/111 |
| spellingShingle | Shakur Haleema Roberts Ian Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply Trials |
| title | Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| title_full | Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| title_fullStr | Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| title_full_unstemmed | Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| title_short | Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| title_sort | response to the brain trial a randomized placebo controlled trial of a bradykinin b2 receptor antagonist anatibant in patients with traumatic brain injury authors reply |
| url | http://www.trialsjournal.com/content/10/1/111 |
| work_keys_str_mv | AT shakurhaleema responsetothebraintrialarandomizedplacebocontrolledtrialofabradykininb2receptorantagonistanatibantinpatientswithtraumaticbraininjuryauthorsreply AT robertsian responsetothebraintrialarandomizedplacebocontrolledtrialofabradykininb2receptorantagonistanatibantinpatientswithtraumaticbraininjuryauthorsreply |